Published in:

01-06-2013

A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia

Authors: Dimitris A. Papanicolaou, S. N. Ather, H. Zhu, Y. Zhou, J. Lutkiewicz, B. B. Scott, J. Chandler

Published in: The journal of nutrition, health & aging | Issue 6/2013